An Open-label Crossover Phase 1 Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif (Interferon Beta-1a) in Healthy Volunteers

Trial Profile

An Open-label Crossover Phase 1 Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif (Interferon Beta-1a) in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Apr 2016

At a glance

  • Drugs Interferon beta-1a (Primary) ; Peginterferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Pharmacokinetics
  • Acronyms COMPARE
  • Sponsors Biogen
  • Most Recent Events

    • 08 Apr 2016 Results published in the British Journal of Clinical Pharmacology
    • 04 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top